# OnCo record portec-3 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/portec-3/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "portec-3", "NCT00411138" ;
  schema:name "PORTEC-3"@en ;
  schema:description "Adding chemotherapy to radiation after surgery helped women with high-risk endometrial cancer, especially those whose tumours have a broken p53 gene."@en ;
  schema:url <https://onco.cc/trials/portec-3/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00411138>, <https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30395-X/fulltext> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2006-11-23" ;
  onco:cancers <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/endometrial-p53-abnormal/>, <https://onco.cc/cancers/endometrial-pole-ultramutated/>, <https://onco.cc/cancers/endometrial-nsmp/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/brachytherapy/> ;
  onco:targets <https://onco.cc/targets/tp53/> ;
  onco:companies <https://onco.cc/companies/trog/> ;
  onco:terms <https://onco.cc/terms/endometrial-molecular-classes/> ;
  onco:people <https://onco.cc/people/carien-creutzberg/> .